Login
Toggle navigation
Videos
Categories
Trending
Anders Hinsby, CEO of Orphazyme
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Navigating the rare disease space: Insights from Orphazyme's CEO
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Inside Kardex Mlog: 100 Years of Innovation and Future Plans | Felix Thöni - Chairperson of Kardex Group
00:10:00
Accumulating and Advancing Copper Assets: Insights from Leo Hathaway at One-to-One Mining Conference
00:10:00
From Aerospace to Financial Planning: Guiding Clients to Their Goals
00:10:00
Leading Through Crisis and Innovation: Jane Sun, CEO of Trip.com Group, on Travel, AI, and Empowering Female Leadership
00:10:00
At the StableView TECH18 conference, AlphaNorth Asset Management's CIO Steven Palmer discusses the cannabis investing boom and his preference for tech stocks, including top picks.
00:10:00
AMC: Leading Independent Mining Consultancy for Global Success
00:10:00
Interview with Fernando Lehner, CEO of BVZ Group, on the Business | Fernando Lehner - CEO of bvz holding ag
00:10:00
Cliff Asness Discusses Market Strategies Amid Inflation and Recession Concerns | Cliff Asness, Chief Investment Officer , AQR Capital.
00:10:00
Monument Mining: Advancing Expansion and Exploration Efforts | Cathy Zhai - Director, President, CEO & Interim CFO of Monument Mining Limited
00:10:00
Backs bold entrepreneurs building the future is our main target|Chris Dixon,General Partner,Andreessen Horowitz
00:10:00
ClearBridge's AssetTV panel discussion, featuring Co-Chief Investment Officer Scott Glasser, Portfolio Managers Michael Testorf and Margaret Vitrano, and Investment Strategist Jeffrey Schulze, addresses future risks and opportunities in global equity mark
00:10:00
AltaIR Capital is looking for great teams to support through their journey|Dmitry Firskin,Principal, AltaIR Capital